Blood Transfusion Practices in Intensive Care: A Prospective Observational Binational Study

IMPORTANCE: Blood transfusions are a common and potentially lifesaving intervention in ICU patients but are associated with harm and often transfused inconsistently with guidelines. However, it is not well known how ICU transfusion practice has recently changed and if there is variation in transfusi...

Full description

Saved in:
Bibliographic Details
Published inCritical care explorations Vol. 7; no. 3; p. e1197
Main Authors Flint, Andrew W. J., Poole, Alexis, Raasveld, Senta Jorinde, Bailey, Michael, Brady, Karina, Chen, Pin-Yen, Chen, Yan, Cooper, D. Jamie, French, Craig, Higgins, Alisa, Irving, Adam H., McAllister, Richard E., Neto, Ary Serpa, Trapani, Tony, Waters, Neil, Winearls, James, Reade, Michael C., Wood, Erica M., Vlaar, Alexander P. J., McQuilten, Zoe K.
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.03.2025
Wolters Kluwer
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IMPORTANCE: Blood transfusions are a common and potentially lifesaving intervention in ICU patients but are associated with harm and often transfused inconsistently with guidelines. However, it is not well known how ICU transfusion practice has recently changed and if there is variation in transfusion practice. OBJECTIVES: To describe blood transfusion practices in ICU, the variation in practice across sites, and to compare transfusion practices against national guidelines and with prior published practice. DESIGN, SETTING, AND PARTICIPANTS: A prospective, multicenter, binational, observational study conducted in 40 Australian and New Zealand ICUs from October 2021 to July 2022. All adult (≥ 18 yr) ICU patients admitted over 1 week were included and followed until ICU discharge or 28 days. MAIN OUTCOMES AND MEASURES: Types of transfusion, thresholds and reasons for transfusions, the use of viscoelastic hemostatic assays (VHAs), variation in transfusion practice across sites, and changes in transfusion practice over time. RESULTS: Of 927 patients, 217 (23.4%) received a blood transfusion during their ICU admission-192 (20.7%) received RBCs, 63 (6.8%) received platelets, 49 (5.3%) received fresh frozen plasma (FFP), and 29 (3.1%) received cryoprecipitate. Massive transfusion protocols were implemented nine times for six patients (0.7%). VHA were used in 25 of 268 (9.3%) non-RBC transfusions. Compared with national guidelines, 89.0% of RBC transfusions, 30.3% of platelet, 27.4% of FFP, and 20.0% of cryoprecipitate transfusions were consistent. Compared with ICU transfusion practices in 2008, after adjusting for confounding variables, ICU patients who received RBC and FFP were transfused more units each, and variation in total transfusions across sites increased for RBC, platelets, and FFP. CONCLUSIONS AND RELEVANCE: Blood transfusions are common in ICU, but the practice is heterogeneous and frequently inconsistent with national guidelines, and the number of units transfused per patient has increased. More evidence is required.
Bibliography:This study was funded in part by a National Blood Authority National Blood Sector Research and Development Grant (No. ID508), along with support from the Australian National Health and Medical Research Council funded Blood Synergy (No. 1189490). Drs. Wood and Cooper are supported by a National Health and Medical Research Council (NHMRC) Leadership Fellowship (Nos. 1177784, 2016324). Drs. McQuilten and Higgins are supported by NHMRC Emerging Leadership Fellowships (Nos. 1194811, 2008447). Dr. Vlaar is supported by a Landsteiner Foundation for Blood Research fellowship grant (No. 1931F) and by a personal grant from the Dutch Research Council (Vidi grant number 09150172010047). The remaining authors have disclosed that they do not have any potential conflicts of interest. Drs. Flint, Raasveld, Brady, Cooper, French, Higgins, Irving, Winearls, Reade, Wood, Vlaar, and McQuilten were involved in the concept and design. Dr. Flint, Dr. Poole, Dr. Brady, Dr. Cooper, Dr. French, Dr. Higgins, Dr. Irving, Mr. Waters, Dr. Winearls, Dr. Reade, Dr. Wood, Dr. Vlaar, and Dr. McQuilten obtained funding. Ethics approval was conducted by Drs. Flint, Poole, and McQuilten. The acquisition of data were overseen by Dr. Flint, Dr. Poole, Dr. Raasveld, Dr. Brady, Ms. Chen, Dr. Higgins, Dr. Irving, Mr. McAllister, Dr. Neto, Mr. Trapani, Dr. Wood, Dr. Vlaar, and Dr. McQuilten. Data analysis and statistical analysis were done by Drs. Flint, Bailey, Chen, Higgins, Irving and McQuilten. Drafting of the article was done by Dr. Flint, and all authors were involved in reviewing the final article. Figures were produced by Drs. Flint and Brady. Administrative support was provided by Drs. Flint, Poole, Raasveld, Vlaar, and McQuilten. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (http://journals.lww.com/ccejournal). For information regarding this article, E-mail: zoe.mcquilten@monash.edu; andrew.flint@monash.edu
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:2639-8028
2639-8028
DOI:10.1097/CCE.0000000000001197